Centchroman - A Magical Pill or a Myth
Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 2
Abstract
MASTALGIA is a common symptom experienced by most of the females and most common complaint encountered in outpatient department. Many agents have been tried but till now ideal treatment still awaits. Centchroman (ormeloxifene) is a selective estrogen receptor modulator. Method: 56 Eligible patients of cyclic as well as non cyclic mastalgia were enrolled in our study to evaluate the efficacy of centchroman. Patients were treated with centchroman 30 mg daily for three months. Patients were followed at 4, 8, 12 weeks up to a period of 6 months. Patients were assessed using VAS score (visual analogue pain score) and breast pain chart. Results: At 12 weeks, 87% women achieved reduction in pain score <3. Centchroman is an effective, safe, inexpensive and easily available drug for mastalgia. Except for 3 patients who had delay of menstruation 7- 10 days.
Authors and Affiliations
Natasha Thakur
Keywords
Related Articles
- EP ID EP277245
- DOI -
- Views 61
- Downloads 0
Bacteriological profile and antibiotic resistance pattern of isolates from neonatal septicemia patients in tertiary care hospital central India
Background: Neonatal septicemia still a major cause of mortality and morbidity worldwide. Blood culture is the main stay in the diagnosis of septicemia. Emergence of drug resistant bacterial strains is a major problem in...
Clinical Study of Osteosynthesis in Fracture Neck of Femur
The aim of the study is to analyse a viable treatment option for fracture neck of femur – considered to be difficult in achieving union. Objectives: To evaluate the efficacy of multiple cancellous screws as a treatment f...
Leukemia Cutis with Acute Myelomonocytic Leukemia Presenting As a Benign Appearing Maculopapular Rash: A Rare and Interesting Case Report
A 54 years old male came with the complaints of raised multiple maculopapular lesions involving the forehead and lateral side of the nose. Skin biopsy showed thinning of epidermis and diffuse monomorphic population of in...
Adjuvant Therapy in Endometrial Carcinoma: Comparing Outcomes of Low Dose Rate (LDR) and High Dose Rate (HDR) Brachytherapy
Background: Endometrial cancer is the sixth most common cancer in women worldwide, with 320,000 new cases diagnosed in 2012 with good survival outcomes with adequate treatment. Studies have proven that brachytherapy with...
Variation of ABO and Rh Blood Groups among Undergraduates
Aim/Objective: The present study aim is to determine the most common blood groups for purpose of emergency blood transfusion and to compare with other studies. Research Methodology: The observational cross-sectional stud...